Holtzman Douglas 4
4 · Icosavax, Inc. · Filed Nov 14, 2022
Insider Transaction Report
Form 4
Icosavax, Inc.ICVX
Holtzman Douglas
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-11-10+82,580→ 82,580 totalExercise: $2.47Exp: 2032-11-09→ Common Stock (82,580 underlying)
Footnotes (1)
- [F1]One-third (1/3rd) of the shares subject to the option shall vest on each of the first three anniversaries of November 10, 2022, subject to the reporting person's continued service through the applicable vesting date.